LLY

808.07

0%↓

JNJ

155.14

-0.84%↓

ABBV

191.24

+0.99%↑

NVO

78.61

-0.99%↓

UNH

310.49

+2.21%↑

LLY

808.07

0%↓

JNJ

155.14

-0.84%↓

ABBV

191.24

+0.99%↑

NVO

78.61

-0.99%↓

UNH

310.49

+2.21%↑

LLY

808.07

0%↓

JNJ

155.14

-0.84%↓

ABBV

191.24

+0.99%↑

NVO

78.61

-0.99%↓

UNH

310.49

+2.21%↑

LLY

808.07

0%↓

JNJ

155.14

-0.84%↓

ABBV

191.24

+0.99%↑

NVO

78.61

-0.99%↓

UNH

310.49

+2.21%↑

LLY

808.07

0%↓

JNJ

155.14

-0.84%↓

ABBV

191.24

+0.99%↑

NVO

78.61

-0.99%↓

UNH

310.49

+2.21%↑

Search

Agilent Technologies Inc

Gesloten

SectorGezondheidszorg

119.88 -0.66

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

119.6

Max

122.49

Belangrijke statistieken

By Trading Economics

Inkomsten

-103M

215M

Verkoop

-13M

1.7B

K/W

Sectorgemiddelde

28.754

51.748

EPS

1.31

Dividendrendement

0.85

Winstmarge

12.89

Werknemers

18,000

EBITDA

-94M

373M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+13.23% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.85%

2.35%

Volgende Winsten

20 aug 2025

Volgende dividenddatum

23 jul 2025

Volgende Ex Dividend datum

1 jul 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-5.7B

33B

Vorige openingsprijs

120.54

Vorige sluitingsprijs

119.88

Nieuwssentiment

By Acuity

24%

76%

50 / 380 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

Agilent Technologies Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

14 aug 2024, 09:29 UTC

Winsten

UBS Net Profit Beats Expectations on Credit Suisse Savings -- 3rd Update

14 jan 2025, 13:05 UTC

Acquisities, Fusies, Overnames

Topicus.com in Agreement to Acquire Cipal Schaubroeck in Belgium >

Peer Vergelijking

Prijswijziging

Agilent Technologies Inc Prognose

Koersdoel

By TipRanks

13.23% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 136.46 USD  13.23%

Hoogste 165 USD

Laagste 115 USD

Gebaseerd op 13 Wall Street-analisten die 12-maands prijsdoelen bieden voor Agilent Technologies Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

13 ratings

7

Buy

6

Hold

0

Sell

Technische score

By Trading Central

107.45 / 109.25Steun & Weerstand

Korte Termijn

Strong Bullish Evidence

Gemiddeld Termijn

Weak Bearish Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

50 / 380 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.